Evolution of the Average Target: Core Laboratories Inc.

Evolution of the Target Price: Core Laboratories Inc.

Changes in Analyst Recommendations: Core Laboratories Inc.

544b82ed81f93b28.z2a9ka-IpOcF2kh3n-xtI0_8o_qtnc5qeVqd42nUfgE.rALV697N-95xogwi_b0VZArOyLXnwqMsTG_frzy1G0D7Ivr3-d_eoHPoLw~3f3d8161fda60b87d3616a5d9422980f
25-03-12 Citigroup Upgrades Core Laboratories to Neutral From Sell, Adjusts Price Target to $16 From $15 MT
25-03-06 Zephirin Adjusts Price Target on Core Laboratories to $18 From $22, Maintains Buy Rating MT
24-10-25 The Zephirin Group Upgrades Core Laboratories to Buy from Hold; Adjusts Price Target to $22 from $18 MT
24-10-25 Zephirin Group Upgrades Core Laboratories to Buy Medium Risk From Hold Medium Risk, Raises Price Target to $22 From $18 MT
24-07-15 Piper Sandler Adjusts Core Laboratories Price Target to $17 From $18, Maintains Neutral Rating MT
24-01-29 Stifel Adjusts Price Target on Core Laboratories to $21 From $23, Maintains Hold Rating MT
23-09-18 Citigroup Trims Price Target on Core Laboratories to $20 From $21, Maintains Sell Rating MT
23-07-31 Piper Sandler Adjusts Core Laboratories' Price Target to $21 From $18, Keeps Neutral Rating MT
23-06-30 Citigroup Downgrades Core Laboratories to Sell From Neutral, Trims Price Target to $21 From $22 MT
23-05-01 Morningstar Upgrades Core Laboratories to Buy From Hold, $29 Price Target MT
23-05-01 Piper Sandler Adjusts Core Laboratories' Price Target to $19 From $18, Keeps Neutral Rating MT
23-04-28 Stifel Adjusts Core Laboratories' Price Target to $25 From $24, Keeps Hold Rating MT
23-04-18 BofA Downgrades Core Laboratories to Underperform From Neutral, Price Target is $21.50 MT
23-02-07 Citigroup Adjusts Price Target on Core Laboratories N.V to $26 From $21, Maintains Neutral Rating MT
23-01-09 BofA Securities Upgrades Core Laboratories to Neutral From Underperform MT
22-10-07 Citigroup Upgrades Core Laboratories to Neutral From Sell, Adjusts Price Target to $17 From $24 MT
22-09-26 Morgan Stanley Downgrades Core Laboratories to Underweight From Equal Weight, Keeps $20 Price Target MT
22-08-02 Cowen Lowers Core Laboratories Price Target to $17 From $22, Maintains Market Perform Rating MT
22-08-01 Morgan Stanley Lowers Core Laboratories' Price Target to $20 From $22, Maintains Equalweight Rating MT
22-07-15 BofA Securities Adjusts Core Laboratories Price Target to $17 From $25, Maintains Underperform Rating MT
22-07-13 Morgan Stanley Adjusts Core Laboratories' Price Target to $22 from $32, Keeps Equalweight Rating MT
22-07-13 Morgan Stanley Adjusts Core Laboratories N.V 's Price Target to $22 From $32, Keeps Equalweight Rating MT
22-05-02 Morgan Stanley Adjusts Core Laboratories' Price Target to $32 from $35, Keeps Equalweight Rating MT
22-04-18 Piper Sandler Downgrades Core Laboratories to Underweight From Neutral MT
22-04-11 Morgan Stanley Adjusts Core Laboratories' Price Target to $35 from $30, Keeps Equalweight Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+9.81%
+12.33%
+32.29%
- - +49.25%
- - -
+37.84%
+50.37%
Average +31.98%
Weighted average by Cap. +16.29%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
12.72USD
Average target price
16.33USD
Spread / Average Target
+28.41%
High Price Target
22.00USD
Spread / Highest target
+72.96%
Low Price Target
12.00USD
Spread / Lowest Target
-5.66%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Citigroup
Zephirin Group
Zephirin
Stifel Nicolaus
Piper Sandler
Morningstar
BofA Securities
Morgan Stanley
Cowen
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
12.72USD
Average target price
16.33USD
Spread / Average Target
+28.41%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CLB Stock
  4. HJ1 Stock
  5. Consensus Core Laboratories Inc.
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!